Article Details

Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 Trial - Stockhouse

Retrieved on: 2022-10-04 17:10:37

Tags for this article:

Click the tags to see associated articles and topics

Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 Trial - Stockhouse. View article details on hiswai:

Excerpt

Robust, highly consistent efficacy demonstrated in mCRPC both with or withouthomologous recombination repair gene mutations. Pfizer Inc. (NYSE: PFE) ...

Article found on: stockhouse.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up